• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Newsroom

    ​MDH_Release_Header_2021.PNG

    August 13, 2021

    Media Contact:

    Deidre McCabe, Director, Office of Communications, 410-767-3536

    Charles Gischlar, Deputy Director, Media Relations, 410-767-6491


    Media Advisory: Maryland Department of Health Statement on Approval of Pfizer and Moderna COVID-19 Vaccines for Immunocompromised individuals.


    Baltimore, MD -  Today, the U.S. Centers for Disease Control and Prevention (CDC) approved the U.S. Food and Drug Administration’s (FDA) amendment of the emergency use authorizations for the Pfizer-BioNTech and Moderna COVID-19 vaccines to allow specific individuals with compromised immune systems to receive a third additional vaccine dose.  


    “We welcome and fully support the CDC’s approval to administer a third dose of Pfizer or Moderna vaccine to immunocompromised Americans,” said Maryland Department of Health Secretary Dennis R. Schrader. “This is another important tool we can use to protect our most vulnerable Maryland residents and we encourage them to get this third shot and for health care providers to begin administering them as soon as possible.”


    While people who are immunocompromised make up about 3% of the U.S. adult population, they are especially vulnerable to COVID-19 because they are more at risk of serious, prolonged illness. Included in CDC’s recommendation are people with a range of conditions, such as recipients of organ or stem cell transplants, people with advanced or untreated HIV infection, active recipients of treatment for cancer, people who are taking some medications that weaken the immune system, and others.  A full list of conditions can be found on CDC’s website and patients should talk to their doctors to determine if they need an additional dose and what the timing of that dose should be. CDC does not recommend additional doses for any other population at this time.

     

    For the most recent Maryland COVID-19 data, visit coronavirus.maryland.gov.


    -###-

    The Maryland Department of Health is dedicated to protecting and improving the health and safety of all Marylanders through disease prevention, access to care, quality management and community engagement. 


    Follow us at http://www.twitter.com/MDHealthDept and https://www.facebook.com/MDHealthDept.    ​